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SYNOPSIS In 21 patients with megaloblastic anaemia associated with the tropical malabsorption syndrome serum vitamin B12 levels have been measured serially before and during parenteral folic acid therapy.
In 11 patients there was a significant rise in serum B12 levels, reaching a peak three to 17 days after starting the folic acid. In three of these cases, absorption of labelled B12 was the same before and after the administration of folic acid. In two cases there was a fall in serum B12 levels and in seven there was no change. In one case small amounts of folic acid produced no change in serum B12 levels, whereas larger doses produced a prompt but transient rise.
A rise in the serum vitamin B12 levels in patients treated with folic acid has been noticed by several workers (Narayanan, Shenoy, and Ramasarma, 1956, 1957; Narayanan, 1961; Molin and Ross, 1957) . It is the purpose of this communication to report further observations on the effect of folic acid therapy on the serum vitamin B12 levels of patients with megaloblastic anaemia associated with the tropical malabsorption syndrome.
MATERIALS AND METHODS
Serum vitamin B12 estimations were performed by the method of Ross, Hutner, and Bach (1957) (Baker and Mollin, 1955) . Twenty-one patients suffering from the malabsorption syndrome or 'idiopathic tropical steatorrhoea' and associated megaloblastic anaemia (Baker 1957 (Baker , 1958 were studied as hospital in-patients. In each case patients were kept on the same diet as they had been having before admission, the patients' relatives supplying their own food from home. In every case there was a control period of at least 10 days in hospital before any therapy was begun, and subsequently daily intramuscular injections of folic acid were given. In Cases 1 to 20, 15 mg. a day was given for 20 to 30 days. In Case 21, 0-2 mg. was given daily for 22 days and then the dose was increased to 15 mg. a day for 28 days. No other specific therapy was given Received for publication 30 September 1961 during the course of the study. The serum vitamin B12 levels in the plasma were estimated at regular intervals.
RESULTS
SERUM B12 LEVELS The changes in the serum B12 levels are shown in Fig. 1 . In 11 patients (Fig. 1 , Cases 1 to 11) there was a significant rise in serum B12 levels reaching a maximum in three to 17 days. In Case 1 this rise in serum levels was sustained throughout the period of observation. Case 7 left hospital on the fourth day of folic acid therapy. In all the other cases the rise in serum levels was subsequently followed by a fall with a tendency to return to pre-treatment lIvels.
In two patients there was a slight fall ( Fig. 1 , Cases 12 and 13), and in seven patients there was no significant change in serum vitamin B12 levels ( Fig. 1 , Cases 14 to 20).
In Case 21 there was no change in serum B12 level when a dose of 0-2 mg. of folic acid was given daily, but a transient rise was observed when the dose was increased to 15 mg. a day (Fig. 2) . VITAMIN B12 ABSORPTION In three patients (Cases 1, 6, and 8) in whom folic acid produced a rise in serum B12 levels, B12 absorption before and after folic acid was measured. In each case B12 absorption was defective, and there was no significant improvement following folic acid administration (Fig. 3) . (98-5 ,u,ug./ml.) than in the latter (77 3 ppg./ml.).
However, Case 3, in which there was a rise in B12 levels, had pre-treatment serum levels of 20 to 25 ,u,ug./ml., a level as low as any in the group which did not show a rise. Narayanan et al. (1957) have suggested that those with greater body stores are those more likely to show a rise in serum levels. It may well be that pre-treatment serum levels do not always accurately indicate the level of body stores, but at least one patient (Case 1) was known to have had a B12 absorptive defect for five years and his body stores must therefore have been low; nevertheless he showed a prompt rise in serum levels after the administration of folic acid.
The maximum rise in serum vitamin B12 levels observed ranged from 100 to 460 ,u,ug./ml. If we assume that the total plasma volume is 3 litres this means a total increase in the plasma B12 of about 1-5 ,ug. This could come about either by an improved absorption of B12 from the gastrointestinal tract or by an internal shift of vitamin B12 from the tissue stores to the plasma.
The fact that in three cases the absorption of radioactive vitamin B12 before and after the administration of folic acid was unchanged suggests that improved absorption is not the explanation for the rise in serum levels.
The initial rise in serum B12 levels could be explained on the basis of mobilization of B12 from 'labile' body stores, presumably in the liver, and the subsequent fall in serum levels occurring when these labile stores were exhausted. The patient described by Mollin and Ross (1957) Wilson and Pitney (1955) found that in monkeys fed on a folic acid-deficient diet the serum B12 levels Changes in serum vitanmin B12 levels in patients with megaloblastic anaemia treated with folic acid 277 fell, and in two out of three such animals given folic acid there was a rise in serum B12 levels followed by a fall. They suggested, without any direct evidence, that the folic acid deficiency depressed B12 absorption which was improved on giving folic acid. Cox, Meynell, Gaddie, and Cooke (1959) , in 13 patients with iron-deficiency anaemia and low serum B12 levels, found a rise in serum B12 following iron administration. The peak rise, however, in their cases was much later than in our patients given folic acid, and the mechanism involved may be quite different.
The changes in serum B12 levels after folic acid administration underline the difficulties in diagnosis which may occur when folic acid is given to patients before adequate investigations have been undertaken. The use of folic acid may convert a low serum B12 level, even in a patient with depleted B12 stores, into a normal or near normal serum level, thus masking the diagnosis. Further, random serum B12 estimations may be misleading in assessing the B12 status of an individual, unless the folic acid status of the patient is also known.
